Quinazoline Based HDAC Dual Inhibitors as Potential Anti-Cancer Agents

Cancer is the most devastating disease and second leading cause of death around the world. Despite scientific advancements in the diagnosis and treatment of cancer which can include targeted therapy, chemotherapy, endocrine therapy, immunotherapy, radiotherapy and surgery in some cases, cancer cells...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhuguru, Jyothi, Ghoneim, Ola A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000668/
https://www.ncbi.nlm.nih.gov/pubmed/35408693
http://dx.doi.org/10.3390/molecules27072294

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000668/
https://www.ncbi.nlm.nih.gov/pubmed/35408693
http://dx.doi.org/10.3390/molecules27072294

Ejemplares similares